Pradel, Clemencito R.

HRN: 22-62-53  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2023
CEFTAZIDIME 1GM (VIAL)
02/20/2023
02/27/2023
IV
1 Gram
Q8
CAP MR
Waiting Final Action 
02/20/2023
CEFTAZIDIME 1GM (VIAL)
02/20/2023
02/26/2023
IV
1g
Q8
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: